| Ident. | Authors (with country if any) | Title |
|---|
| 000084 (2013) |
Vincent Degos [France, États-Unis] ; Stéphane Peineau [France, Royaume-Uni] ; Cora Nijboer [Pays-Bas] ; Angela M. Kaindl [France, Allemagne] ; Stéphanie Sigaut [France] ; Géraldine Favrais [France] ; Frank Plaisant [France] ; Natacha Teissier [France] ; Elodie Gouadon [France] ; Alain Lombet [France] ; Elie Saliba [France] ; Graham L. Collingridge [Royaume-Uni, Canada, Corée du Sud] ; Mervyn Maze [États-Unis] ; Ferdinando Nicoletti [Italie] ; Cobi Heijnen [Pays-Bas] ; Jean Mantz [France] ; Annemieke Kavelaars [Pays-Bas] ; Pierre Gressens [France, Royaume-Uni] | G protein–coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation‐induced sensitization to excitotoxic neurodegeneration |
| 000173 (2012) |
Benedicte Ballanger [France] ; Helene Klinger [France] ; Julien Eche [France] ; Jérôme Lerond [France] ; Anne-Evelyne Vallet [France] ; Didier Le Bars [France] ; Leon Tremblay [France] ; Véronique Sgambato-Faure [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease |
| 000187 (2012) |
Martin Egeland [Suède] ; Xiaoqun Zhang [Suède] ; Mark J. Millan [France] ; Elisabeth Mocaer [France] ; Per Svenningsson [Suède] | Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice |
| 000355 (2011) |
Cécile Bétry [France] ; Adeline Etiévant [France] ; Laura Lambás-Se As [France] ; Andrew C. Mccreary [Pays-Bas] ; Nasser Haddjeri [France] | In vivo effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5‐HT1A receptor agonist, on rat dopamine and serotonin neuronal activity |
| 000620 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
| 000649 (2009) |
Frank Antonicelli ; Georges Bellon ; Sandrine Lorimier [France] ; William Hornebeck | Role of the elastin receptor complex (S‐Gal/Cath‐A/Neu‐1) in skin repair and regeneration |
| 000674 (2009) |
O. Outteryck [France] ; P. Richard [France] ; A. Lacour [France] ; E. Fournier [France] ; H. Zéphir [France] ; K. Gaudon [France] ; B. Eymard [France] ; D. Hantaï [France] ; P. Vermersch [France] ; T. Stojkovic [France] | Novel ϵ subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome |
| 000757 (2008) |
Abdessamad El Laoui [France] ; Frédéric Schmidt [France] ; Marianne Sarr [France] ; Didier Decaudin [France] ; Jean-Claude Florent [France] ; Ludger Johannes [France] | Synthesis and Properties of a Mitochondrial Peripheral Benzodiazepine Receptor Conjugate |
| 000A10 (2006) |
Ying-Hui Wu [Pays-Bas] ; Jiang-Ning Zhou [République populaire de Chine] ; Rawien Balesar [Pays-Bas] ; Unga Unmehopa [Pays-Bas] ; Aimin Bao [Pays-Bas] ; Ralf Jockers [France] ; Joop Van Heerikhuize [Pays-Bas] ; Dick F. Swaab [Pays-Bas] | Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin‐releasing hormone |
| 000A48 (2006) |
Lara Fallon [Canada] ; Catherine M. L. Blanger [Canada] ; Amadou T. Corera [Canada] ; Maria Kontogiannea [Canada] ; Elsa Regan-Klapisz [Pays-Bas] ; France Moreau [Canada] ; Jarno Voortman [Pays-Bas] ; Michael Haber [Canada] ; Genevive Rouleau [Canada] ; Thorhildur Thorarinsdottir [Canada] ; Alexis Brice [France] ; Paul M. P. Van Bergen En Henegouwen [Pays-Bas] ; Edward A. Fon [Canada] | A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)KAkt signalling |
| 000B09 (2005) |
Incarnation Aubert [France] ; Céline Guigoni [France] ; Kerstin H Kansson [Suède] ; Qin Li [République populaire de Chine] ; Sandra Dovero [France] ; Nicole Barthe [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Gilberto Fisone [Suède] ; Bertrand Bloch [France] ; Erwan Bezard [France] | Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia |
| 000B60 (2004) |
Paul R. Gouldson [Royaume-Uni] ; Nathan J. Kidley [Royaume-Uni] ; Robert P. Bywater [Danemark] ; Georgios Psaroudakis [Royaume-Uni] ; Harry D. Brooks [Royaume-Uni] ; Constantino Diaz [France] ; David Shire [France] ; Christopher A. Reynolds [Royaume-Uni] | Toward the active conformations of rhodopsin and the β2‐adrenergic receptor |
| 000D18 (2003) |
S. Jégou [France] ; M. El Yacoubi [France] ; L. Mounien [France] ; C. Ledent [Belgique] ; M. Parmentier [Belgique] ; J. Costentin [France] ; J. Vaugeois [France] ; H. Vaudry [France] | Adenosine A2A Receptor Gene Disruption Provokes Marked Changes in Melanocortin Content and Pro‐Opiomelanocortin Gene Expression |
| 000D42 (2002) |
Lionel Bert [France] ; Daniel Rodier [France] ; Isabelle Bougault [France] ; Nathalie Allouard [France] ; Gérard Le-Fur [France] ; Philippe Soubrié [France] ; Régis Steinberg [France] | Permissive role of neurokinin NK3 receptors in NK1 receptor‐mediated activation of the locus coeruleus revealed by SR 142801 |
| 000E64 (2001) |
Frédéric Dolle [France] ; Héric Valette [France] ; Françoise Hinnen [France] ; Françoise Vaufrey [France] ; Stéphane Demphel [France] ; Christine Coulon [France] ; Michéle Ottaviani [France] ; Michel Bottlaender [France] ; Christian Crouzel [France] | Synthesis and preliminary evaluation of a carbon‐11‐labelled agonist of the α7 nicotinic acetylcholine receptor |
| 000F05 (2001) |
I. Van Pottelbergh [Belgique] ; S. Lumbroso ; S. Goemaere ; C. Sultan ; J. M. Kaufman [Belgique] | Lack of influence of the androgen receptor gene CAG‐repeat polymorphism on sex steroid status and bone metabolism in elderly men |
| 000F06 (2001) |
C. Marin [Espagne] ; A. Jiménez [Espagne] ; M. Bonastre [Espagne] ; M. Vila [France, États-Unis] ; Yves Agid [France] ; E. C. Hirsch [France] ; E. Tolosa [Espagne] | LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa‐induced motor alterations in Parkinsonian rats |
| 000F17 (2001) |
Malika El Yacoubi [France] ; Catherine Ledent [Belgique] ; Marc Parmentier [Belgique] ; Ennio Ongini [Italie] ; Jean Costentin [France] ; Jean-Marie Vaugeois [France] | In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261 |
| 001063 (2000) |
M. G Murer [Argentine, France] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A Kelly [États-Unis] ; D. K Grandy [États-Unis] ; M. J Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice |
| 001157 (2000) |
C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] | Continuous dopamine-receptor stimulation in early Parkinson's disease |
| 001172 (2000) |
Gabriella Künig [Suisse] ; Klaus L. Leenders [Suisse, Pays-Bas] ; Rosario Sanchez-Pernaute [Espagne] ; Angelo Antonini [Italie] ; Peter Vontobel [Suisse] ; Aalt Verhagen [Suisse] ; Ilonka Günther [France] | Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomography |
